2018

• Laing, B.et al. 2018. An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Review of Gastroenterology and Hepatology 12(10), pp. 969-983. (10.1080/17474124.2018.1505497)

2017

• Vaidyanathan, V.et al. 2017. Effect of ageing and single nucleotide polymorphisms associated with the risk of aggressive prostate cancer in a New Zealand population. Molecular BioSystems 13(10), pp. 1967-1980. (10.1039/C7MB00203C)
• Vaidyanathan, V.et al. 2017. Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach. Molecular Biosystems 13(4), pp. 681-698. (10.1039/C6MB00873A)

2016

• Boss, A.et al. 2016. Human intervention study to assess the effects of supplementation with olive leaf extract on peripheral blood mononuclear cell gene expression. International Journal of Molecular Sciences 17(12), pp. -., article number: 2019. (10.3390/ijms17122019)
• Vaidyanathan, V.et al. 2016. Prostate Cancer: Is It a Battle Lost to Age?. Geriatrics 1(4), article number: 27. (10.3390/geriatrics1040027)
• Boss, A.et al. 2016. Evidence to support the anti-cancer effect of olive leaf extract and future directions. Nutrients 8(8), article number: 513. (10.3390/nu8080513)
• D'Souza, S.et al. 2016. Associations between the KIAA0319 dyslexia susceptibility gene variants, antenatal maternal stress, and reading ability in a longitudinal birth cohort. Dyslexia 22(4), pp. 379-393. (10.1002/dys.1534)
• D'Souza, S.et al. 2016. Environmental and genetic determinants of childhood depression: The roles of DAT1 and the antenatal environment. Journal of Affective Disorders 197, pp. 151-158. (10.1016/j.jad.2016.03.023)
• Vaidyanathan, V.et al. 2016. Are We Eating Our Way to Prostate Cancer - A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific Transfer of miR-150. Non-Coding RNA 2(2), article number: 2. (10.3390/ncrna2020002)
• Ferguson, L.et al. 2016. Identification of potential anticancer activities of novel ganoderma lucidum extracts using gene expression and pathway network analysis. Genomics Insights, pp. 1-16. (10.4137/GEI.S32477)
• Lin, Z.et al. 2016. A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. Molecular Biosystems 12(3), pp. 839-849. (10.1039/C5MB00554J)
• Ferguson, L. R.et al. 2016. The role of vitamin D in reducing gastrointestinal disease risk and assessment of individual dietary intake needs: Focus on genetic and genomic technologies. Molecular Nutrition & Food Research 50(1), pp. 119-133. (10.1002/mnfr.201500243)

2015

• Marlow, G.et al. 2015. Food intolerance: associations with the rs12212067 polymorphism of FOXO3 in Crohn's Disease patients in New Zealand. Journal of Nutrigenetics and Nutrigenomics 8(2), pp. 70-80. (10.1159/000435783)
• Ojcius, D. M.et al. 2015. Extracts of feijoa inhibit toll-like receptor 2 signaling and activate autophagy implicating a role in dietary control of IBD. PLoS ONE 10(6), article number: e0130910. (10.1371/journal.pone.0130910)
• Marlow, G.et al. 2015. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatric Allergy and Immunology 26(3), pp. 262-271. (10.1111/pai.12371)
• Folkard, D. L.et al. 2015. Effect of Sulforaphane on NOD2 via NF-?B: implications for Crohn's disease. Journal of Inflammation 12(1), article number: 6. (10.1186/s12950-015-0051-x)

2014

• Nasef, N.et al. 2014. Anti-inflammatory activity of fruit fractions in vitro, mediated through toll-like receptor 4 and 2 in the context of inflammatory bowel disease. Nutrients 6(11), pp. 5265-5279. (10.3390/nu6115265)

2013

• Marlow, G.et al. 2013. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Human Genomics 7(1), article number: 24. (10.1186/1479-7364-7-24)
• Marlow, G., van Gent, D. and Ferguson, L. R. 2013. Why interleukin-10 supplementation does not work in Crohn's disease patients. World Journal of Gastroenterology 19(25), pp. 3931-3941. (10.3748/wjg.v19.i25.3931)

2010

• Mahjneh, I.et al. 2010. A new distal myopathy with mutation in anoctamin 5. Neuromuscular Disorders 20(12), pp. 791-795. (10.1016/j.nmd.2010.07.270)
• Bolduc, V.et al. 2010. Recessive mutations in the putative calcium-activated chloride channel anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. American Journal of Human Genetics 86(2), pp. 213-221. (10.1016/j.ajhg.2009.12.013)

2007

• Jaiswal, J. K.et al. 2007. Patients with a non-dysferlin miyoshi myopathy have a novel membrane repair defect. Traffic 8(1), pp. 77-88. (10.1111/j.1600-0854.2006.00505.x)